Skip to main content
CHEMCLIN DIAGNOSTICS CO., LTD. logo

CHEMCLIN DIAGNOSTICS CO., LTD. — Investor Relations & Filings

Ticker · 688468 ISIN · CNE100005311 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 511 across all filing types
Latest filing 2021-05-24 Notice of Dividend Amou…
Country CN China
Listing Shanghai Stock Exchange 688468

About CHEMCLIN DIAGNOSTICS CO., LTD.

https://www.chemclin.com/

CHEMCLIN DIAGNOSTICS CO., LTD. specializes in the research, development, and manufacturing of in vitro diagnostic systems and reagents. The company is primarily recognized for its proprietary Light-initiated Chemiluminescent Assay (LiCA) technology, a homogeneous chemiluminescence platform that eliminates the need for washing steps, thereby enhancing testing efficiency and precision. Its product portfolio includes fully automated immunoassay analyzers and a comprehensive range of diagnostic kits covering infectious diseases, cardiac markers, thyroid function, tumor markers, and reproductive health. By integrating advanced biotechnology with automated instrumentation, the company provides clinical laboratories and medical institutions with high-sensitivity diagnostic solutions designed to improve patient care and laboratory workflow.

Recent filings

Filing Released Lang Actions
科美诊断技术股份有限公司2020年度利润分配方案的公告
Notice of Dividend Amount Classification · 95% confidence The document is a formal announcement from the board of directors of 科美诊断技术股份有限公司 regarding the 2020 annual profit distribution plan. It states that the company will not distribute dividends or convert capital reserves into shares for the year 2020. The document includes detailed explanations about the company's financial performance, industry context, development stage, and reasons for retaining earnings. It also mentions that the profit distribution plan will be submitted to the 2020 annual general meeting for approval. The document is relatively short (3142 characters) and focuses on the dividend distribution decision rather than presenting full financial statements or comprehensive annual report content. This type of document fits the category of Notice of Dividend Amount (DIV), as it announces the dividend policy and payment decisions for the fiscal year.
2021-05-24 Chinese
中信证券股份有限公司关于科美诊断技术股份有限公司使用闲置募集资金进行现金管理的核查意见
Capital/Financing Update Classification · 95% confidence The document is a detailed report from a securities company acting as a sponsor for a listed company regarding the use of idle raised funds for cash management. It includes specifics about the raised funds, investment projects, investment purpose, amount, types, duration, implementation, risk control, and approval procedures. It references regulatory guidelines and approvals but does not present financial statements or earnings data. The document is about the management and use of raised funds, specifically cash management of idle funds, which aligns with a Capital/Financing Update rather than a full financial report or audit. The length is under 5,000 characters, but the content is substantive and detailed, not merely an announcement or certification. Therefore, the best fitting category is Capital/Financing Update (CAP).
2021-05-24 Chinese
科美诊断技术股份有限公司关于召开2020年年度股东大会的通知
AGM Information Classification · 100% confidence The document is a notice about the convening of the 2020 Annual General Meeting (AGM) of 科美诊断技术股份有限公司, including details such as the date, voting methods, agenda items, and instructions for shareholders. It does not contain the actual reports or financial statements but rather the announcement and procedural information related to the AGM. The document length is 3748 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, it fits the category of AGM Information (AGM-R).
2021-05-24 Chinese
科美诊断技术股份有限公司章程
Governance Information Classification · 95% confidence The document is titled as the Articles of Association (章程) of 科美诊断技术股份有限公司 (Chemclin Diagnostics Co., Ltd.) dated June 2021. It contains detailed provisions on company organization, shareholder rights, board structure, share issuance, capital changes, shareholder meetings, and governance rules. It references relevant laws and regulations such as the Company Law of China, Securities Law, and Shanghai Stock Exchange listing rules. The content is a comprehensive governance document outlining the company's internal rules and procedures rather than a financial report, announcement, or meeting material. It does not contain financial statements, earnings data, or voting results. Therefore, it fits the category of Governance Information (CGR), which covers reports detailing the company's internal rules, board structure, and governance practices.
2021-05-24 Chinese
科美诊断技术股份有限公司2020年度董事会审计委员会履职报告
Regulatory Filings
2021-05-24 Chinese
科美诊断技术股份有限公司关于续聘2021年度审计机构的公告
Audit Report / Information Classification · 95% confidence The document is an announcement regarding the proposed reappointment of an audit firm (信永中和会计师事务所) for the company's 2021 audit. It details the audit firm's background, qualifications, independence, and the approval process by the audit committee, independent directors, and the board of directors. It also states that the appointment is subject to shareholder approval at the 2020 annual general meeting. The document does not contain any actual audit report, financial statements, or audit results. It is a formal announcement about the audit firm appointment process and related governance matters. Given the content and length (2461 characters), it fits best as an Audit Report / Information announcement (AR) rather than the full audit report or annual report itself. FY 2020
2021-05-24 Chinese

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.